Current FDA approved indications for use of low molecular weight heparins (LMWHs).
| . | Indication for LMWH . | |||
|---|---|---|---|---|
| Drug . | Treatment of Venous Thromboembolism . | Prophylaxis – Total Knee . | Prophylaxis – Total Hip . | Unstable Angina . |
| * Not FDA approved, but used in other countries at this dose. | ||||
| enoxaparin | 100 IU/kg/ q 12 hr or 150 IU/kg qd | 3000 IU/day bid | 3000 IU/day bid | 100 IU/kg q 12 hr |
| dalteparin | (200 IU/kg once daily)* | ??? | 5000 IU/day | 120 IU/kg q 12 hr |
| tinzaparin | 175 IU/kg/once daily | ??? ? 75 IU/kg/day | ??? ? 75 IU/kg/day ? 4,500 IU/day | ??? |
| . | Indication for LMWH . | |||
|---|---|---|---|---|
| Drug . | Treatment of Venous Thromboembolism . | Prophylaxis – Total Knee . | Prophylaxis – Total Hip . | Unstable Angina . |
| * Not FDA approved, but used in other countries at this dose. | ||||
| enoxaparin | 100 IU/kg/ q 12 hr or 150 IU/kg qd | 3000 IU/day bid | 3000 IU/day bid | 100 IU/kg q 12 hr |
| dalteparin | (200 IU/kg once daily)* | ??? | 5000 IU/day | 120 IU/kg q 12 hr |
| tinzaparin | 175 IU/kg/once daily | ??? ? 75 IU/kg/day | ??? ? 75 IU/kg/day ? 4,500 IU/day | ??? |